tiprankstipranks
CervoMed (CRVO)
NASDAQ:CRVO
US Market

CervoMed (CRVO) Technical Analysis

Compare
1,088 Followers

Technical Sentiment

Overall Consensus
Strong Buy
13Bullish
0Neutral
0Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
CervoMed’s (CRVO) Moving Averages Convergence Divergence (MACD) indicator is 1.74, suggesting CervoMed is a Buy.
CervoMed’s (CRVO) 20-Day exponential moving average is 8.60, while CervoMed’s (CRVO) share price is $11.24, making it a Buy.
CervoMed’s (CRVO) 50-Day exponential moving average is 6.34, while CervoMed’s (CRVO) share price is $11.24, making it a Buy.

CervoMed (CRVO) Pivot Points

Apr 05, 2025, 05:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.26
8.00
8.58
9.32
9.90
10.64
11.22
Fibonacci
8.00
8.51
8.82
9.32
9.83
10.14
10.64
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CervoMed (CRVO) Moving Averages

Apr 05, 2025, 05:39 AM
Period
Simple
Exponential
MA5
10.69Buy
10.97Buy
MA10
10.35Buy
10.15Buy
MA20
8.40Buy
8.60Buy
MA50
4.70Buy
6.34Buy
MA100
5.26Buy
6.82Buy
MA200
10.25Buy
10.93Buy
CervoMed’s (CRVO) 10-Day exponential moving average is 10.15, while CervoMed’s (CRVO) share price is $11.24, making it a Buy.
CervoMed’s (CRVO) 100-Day exponential moving average is 6.82, while CervoMed’s (CRVO) share price is $11.24, making it a Buy.
CervoMed’s (CRVO) stock price is $11.24 and CervoMed’s (CRVO) 50-day simple moving average is 4.70, creating a Buy signal.
CervoMed’s (CRVO) stock price is $11.24 and CervoMed’s (CRVO) 100-day simple moving average is 5.26, creating a Buy signal.
CervoMed’s (CRVO) stock price is $11.24 and CervoMed’s (CRVO) 200-day simple moving average is 10.25, creating a Buy signal.

CervoMed (CRVO) Technical Indicators

Apr 05, 2025, 05:39 AM
Name
Value
Implied Action
RSI (14)
62.10
Neutral
STOCH (9,6)
24.53
Neutral
STOCHRSI (14)
45.52
Neutral
MACD (12,26)
1.74
Buy
ADX (14)
44.47
Neutral
Williams %R
-60.32
Buy
CCI (14)
53.18
Neutral
ATR (14)
1.75
-
Ultimate Oscillator
38.57
Neutral
ROC
74.53
Buy
CervoMed’s (CRVO) Relative Strength Index (RSI) is 62.10, creating a Neutral signal.
CervoMed’s (CRVO) Trend Strength Indicator (ADX) is 44.47, creating a Neutral signal.
CervoMed’s (CRVO) Commodity Channel Index (CCI) is 53.18, creating a Neutral signal.
CervoMed’s (CRVO) Price Rate of Change (ROC) is 74.53, creating a Buy signal.

FAQ

Is CRVO a Buy, Hold, or Sell?
Based on CRVO’s technical indicators, CRVO is a Strong Buy.
    What is CRVO’s RSI (14)?
    CRVO’s RSI (14) is 62.10, which suggests CRVO is a Neutral.
      What is CRVO’s MACD?
      CRVO’s MACD is 1.74, which suggests CRVO is a Buy.
        What is CRVO’s 5-day moving average?
        CRVO’s 5-day moving average is 10.69, which suggests CRVO is a Buy.
          What is CRVO’s 20-day moving average?
          CRVO 20-day moving average is 8.40, which suggests CRVO is a Buy.
            What is CRVO’s 50-day moving average?
            CRVO’s 50-day moving average is 4.70, which suggests CRVO is a Buy.
              What is CRVO’s 200-day moving average?
              CRVO’s 200-day moving average is 10.25, which suggests CRVO is a Buy.
                What is CRVO’s Williams % R (14)?
                CRVO’s Williams % R (14) is -60.32, which suggests CRVO is a Buy.
                  What is CRVO’s CCI (14)?
                  CRVO’s CCI (14) is 53.18, which suggests CRVO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis